Dr. Kern is the Chief of Urologic Oncology and Associate Professor of Surgery in the Murtha Cancer Center at the Uniformed Services University and Walter Reed National Military Medical Center, Bethesda, MD (USA). He is the founding Director of the Testicular cancer Enterprise for Survivorship, Treatment, and Investigational Sciences “TESTIS” Program at the Murtha Cancer Center, USU. He is also the Program Director of the National Capital Consortium Walter Reed Urology Residency. Dr. Kern completed a Society of Urologic Oncology accredited advanced fellowship in Urologic Oncology at Indiana University. Dr. Kern's research interests include the genetics and emerging biomarkers of germ cell testicular cancer, surgical treatment and management of chemotherapy-resistant testicular cancer, and survivorship. He is board certified by the American Board of Urology and a member of the Society of Urologic Oncology, American Urological Association, and Society of Government Service Urologists. Dr Kern is a member of the Board of Directors for the Testicular Cancer Awareness Foundation and an External Advisory Board Member of the Indiana University R01 Platinum Study. Dr. Kern was recognized for excellence in clinical expertise by the United State Army Surgeon General in 2023. Dr. Kern was named the 2025 Young Urologist of the Year by the American Urological Association.